Literature DB >> 11096475

Atrial Tachycardia.

.   

Abstract

The available therapies for atrial tachycardia include the use of antiarrhythmic drugs, radiofrequency catheter ablation, and antiarrhythmic surgery. The growing realization that catheter ablation cures atrial tachycardia with high efficacy and safety has contributed to the increasing popularity of the procedure and makes it the therapy of choice in symptomatic patients. Antiarrhythmic drugs are thought to be effective acutely in 40% to 60% of patients, but their long-term efficacy remains poorly defined. Infrequently, atrioventricular nodal catheter ablation combined with pacing may be needed in patients whose arrhythmias are refractory to antiarrhythmic drugs and curative radiofrequency ablation. Antiarrhythmic surgery has a limited role as a therapy of last resort.

Entities:  

Year:  1999        PMID: 11096475     DOI: 10.1007/s11936-999-0014-8

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  16 in total

1.  Sotalol for atrial tachycardias after surgery for congenital heart disease.

Authors:  G C Beaufort-Krol; M T Bink-Boelkens
Journal:  Pacing Clin Electrophysiol       Date:  1997-08       Impact factor: 1.976

2.  Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease.

Authors:  J K Triedman; D M Bergau; J P Saul; M R Epstein; E P Walsh
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

Review 3.  Focal atrial tachycardia: reanalysis of the clinical and electrophysiologic characteristics and prediction of successful radiofrequency ablation.

Authors:  S A Chen; C T Tai; C E Chiang; Y A Ding; M S Chang
Journal:  J Cardiovasc Electrophysiol       Date:  1998-04

Review 4.  Multifocal atrial tachycardia.

Authors:  J McCord; S Borzak
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

Review 5.  Surgical management of chronic ectopic atrial tachycardia.

Authors:  J E Lowe; P J Hendry; D L Packer; A S Tang
Journal:  Semin Thorac Cardiovasc Surg       Date:  1989-07

6.  Effect of encainide and flecainide on chronic ectopic atrial tachycardia.

Authors:  K P Kunze; K H Kuck; M Schlüter; W Bleifeld
Journal:  J Am Coll Cardiol       Date:  1986-05       Impact factor: 24.094

7.  Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.

Authors:  J C Perry; R L McQuinn; R T Smith; C Gothing; P Fredell; A Garson
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

8.  Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.

Authors:  E L Pritchett; W E Wilkinson
Journal:  Am J Cardiol       Date:  1991-05-01       Impact factor: 2.778

9.  Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.

Authors:  D E Haines; J P DiMarco
Journal:  J Am Coll Cardiol       Date:  1990-05       Impact factor: 24.094

10.  A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.

Authors: 
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.